Pharmaceutical-grade cannabis extracts.

Aureum’s manufacturing facility is currently under construction and will be purpose built to ensure industry best-practice and compliance with the requirements of GMP (Good Manufacturing Practice). This will allow Aureum to work with its established cultivation partners in producing the purest quality pharmaceutical-grade cannabis extracts.

Aureum will offer a complete outsourcing solution from pre-processing of raw material to primary and secondary packaging of products. Our goal is to bring quality to life, and we will do this by always delivering on our promise of consistent quality assured.


Peter Emil Sigetty

Chief Executive Officer

M.S.c in Economics & Business Administration.

Peter is co-founder and CEO of Aureum and has been involved in the Danish medicinal cannabis industry from the beginning. Peter has professional experience in finance and accounting from the global shipping company, A.P. Moller Maersk, at both Group level and in the Tanker industry. Peter started working with business development in the medicinal cannabis industry at Medican, which later led to the establishment of Aureum.

John Reks Jacobsen

Manufacturing and Regulatory Affairs

M.S.c in Pharmacy.

John has 35 years of experience in the pharmaceutical industry and has held various senior positions among other: Managing Director at GK Pharma, Director at Bavarian Nordic and Plant Manager at Orion Pharma. John has experience in a wide range of operational areas such as solid dosage forms, fluids and aseptic products. John possess a high-level knowledge of rules related to GMP, FDA, ISO and HACCP.

Nina Segerlund Jacobsen

Quality Assurance Manager

M.S.c in Pharmacy.

Nina possess a strong quality mindset with 20+ years of experience in the pharmaceutical industry working with QA, QC and Auditing. Nina has worked with companies such as Novartis, Leo Pharma, DAKO, H. Lundbeck and more.

Scroll to Top